• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Inflation Reduction Act

scotus
Pharma

AstraZeneca makes last-chance IRA appeal to US Supreme Court

After a string of Big Pharma defeats challenging the legality of the Medicare price negotiation program, Astra Zeneca is throwing one last Hail Mary.
Kevin Dunleavy Sep 25, 2025 11:08am
law and order concept

Novartis falls in another IRA price negotiation loss for pharma

Sep 12, 2025 10:41am
Lawsuit over pharma drugs
Favicon Fierce Healthcare

Drug price negotiation program sidesteps latest legal obstacle

Aug 7, 2025 3:00pm
Congress senate house government US

Senate revives Orphan Cures Act in Trump's tax bill

Jun 30, 2025 10:09am
Capitol

Orphan Cures Act dropped from Senate reconciliation bill

Jun 17, 2025 11:30am
Trump

Large pharmas likely to endure Trump's pricing, tariff threats: S&P

May 28, 2025 11:16am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings